Toggle light / dark theme

Anti-aging startup backed by Fidelity, Bezos raises $116 million

Senolytics moving into human clinical trials in the next 18 months! One of the greatest pieces of biotech news of 2016.


The Silicon Valley drugmaker is part of a wave of new companies chasing after the fountain of youth.

By Caroline Chen Bloomberg

Read more